Rallybio Corporation (RLYB) Misses Q2 EPS by 30c

Rallybio Corporation (NASDAQ: RLYB) reported Q2 EPS of ($0.67), $0.30 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• Boeing and Bell Boeing receive defense contracts totaling $56.4M
• Northrop Grumman wins $143M in new U.S. defense contracts